Exelixis, Inc.
Current role
EXEL
Dana T. Aftab, Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dana T. Aftab, Ph.D.
Exelixis, Inc. reported in an 8-K filed August 29, 2025 that Dana T. Aftab, Ph.D. was appointed Executive Vice President, Research and Development, effective August 29, 2025.
“On August 29, 2025, the Board of Directors (the "Board") of Exelixis, Inc. (the "Company") appointed Dana T. Aftab, Ph.D., the Company's current Executive Vice President, Discovery and Translational Research and Chief Scientific Officer as Executive Vice President, Research and Development.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Exelixis, Inc. (EXEL)
SEC 8-K
Current2025-08-29–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Exelixis, Inc.
Other people whose current roles at this company are on record from its filings.
- Michael M. Morrissey CEO, Board Member
- Michael Morrissey CEO, Board Member
- Christopher Senner CFO
- Brenda Hefti, J.D., Ph.D. General Counsel
- Brenda J. Hefti General Counsel
- Alan M. Garber, M.D., Ph.D. Board Member
- Carl B. Feldbaum, Esq. Board Member
- Charles Cohen, Ph.D. Board Member
- David E. Johnson Board Member
- George Poste Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.